Juvéderm dermal filler is a non-surgical wrinkle removal gel. It is the latest advance in dermal filler options from Allerga, the makers of Botox Cosmetic. It is the only hyaluronic acid dermal filler developed using a proprietary and technologically advanced manufacturing process that result in a malleable smooth gel that flows easily into the skin, creating a smooth, natural look and feel.
Today’s dermal fillers offer just one convenient option for reclaiming your youthful looks. Since wrinkles and poor skin texture are usually a result of low levels of collagen and hyaluronic acid in the body, dermal fillers act as a ‘filling’ agent to plump up and nourish the skin with the missing acid. Juvéderm is available at medical spas and cosmetic surgeon offices and promise a smoother, more youthful skin texture.
Juvéderm dermal filler contains the highest concentration of non-animal, cross-linked hyaluronic acid of any dermal filler currently available. These unique attributes provide optimal results with a single treatment in the majority of patients and deliver sustained results for up to six months or even longer. Juvéderm is natural, biodegradable and currently the only hyaluronic acid dermal filler that has demonstrated its safety and effectiveness in patients of all skin types and colours.
However, the Juvéderm dermal filler is not advisable on people with the following medical concerns. An opinion from a medical health professional is highly recommended.
*Patients who are using substances that can prolong bleeding, such as aspirin or ibuprofen, as with any injection, may experience increased bruising or bleeding at the injection site. You should inform your healthcare professional before treatment if you are using these types of substances.
*If laser treatment, chemical peeling, or any other procedure based on active dermal response is considered after treatment with Juvéderm dermal filler, there is a possible risk of an inflammatory reaction at the treatment site.
*Juvéderm should be used with caution in patients on immunosuppressive therapy, or therapy used to decrease the body’s immune response, as there may be an increased risk of infection.
*The safety of Juvéderm dermal filler for use during pregnancy, in breastfeeding females, or in patients under 18 years has not been established yet.
*The safety of Juvéderm dermal filler in patients with a history of excessive scarring (e.g., hypertrophic scarring and keloid formations) and pigmentation disorders has not been studied.